AI assistant
InspireMD, Inc. — Director's Dealing 2021
Oct 14, 2021
34187_dirs_2021-10-14_2284677a-b144-4ce0-9170-84fb09c9f50c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2021-10-13
Reporting Person: Slosman Marvin (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-13 | Restricted Stock Units | A | 146567 | — | Acquired | 243470 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-10-13 | Options to purchase common stock (right to buy) | $4.12 | A | 48855 | Acquired | 2031-10-13 | Common Stock (48855) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants | $ | Common Stock () | 5048 | Direct |
Footnotes
F1: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.
F2: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service.
F3: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.